Equity
€236,430 ▲ 19.4%
VH Pharma has made a profit in every financial year since 2022.
VH Pharma
Lifetime
4 annual accounts with figures on one time axispeak €113,138 (2024)
€99,456▼ 12.1%
peak €154,962 (2024)
€38,454▼ 75.2%
peak €236,430 (2025)
€236,430▲ 19.4%
€642,853▼ 17.7%
peak 0 FTE (2023)
0 FTE
Board1 name since 2022
1 directorVan Hove Elien Irène
Documentsfilings and deeds
15-07-202616 days before the deadline
2025abbreviated format
Gross margin from €113,138 to €99,456Result from €154,962 to €38,454Equity from €197,975 to €236,430Debts from €781,386 to €642,853Cash from €6,870 to €8,961
Key points
from the 2025 annual accountsResult
€38,454 ▼ 75.2%
The result fell in 2025 from €154,962 to €38,454.
Turnover
≈ €240,000 estimated
The abbreviated format states no turnover.
Debts
€642,853 73% of the balance sheet
Financial debts 86%Suppliers 1%Taxes and wages 0%Other 13%
€340,486 of the debts are secured on the company's own assets.
Securities
€315,000
Mortgage mandates, new in 2025. 1.3 times equity · not in the 2024 accounts.
Liquidity
0.26 was 1.15 in 2024
Short-term debts fell from €98,270 to €80,931.
Financial institution: outside the modelBankruptcy probability: sector outside the model
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score measures liquidity, leverage and margins against the norms for trading and manufacturing companies. A bank, insurer or financial holding has a very different balance sheet. Those ratios and the score mean nothing here. So there is no financial strength either.
Bankruptcy probability within 12 months
The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
1 signal, which does not raise the risk
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
16 days early
2024
22 days early
2023
8 days early
2022
28 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 5 days before the deadline. In the sector (NACE 64), the median for financial year 2024 was 14 days before the deadline, and 28% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 July (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0788292373
Incorporation
published on 08-07-2022 · Gazette deed
First establishment
Neerbroek 44, Beveren-Kruibeke-Zwijndrecht
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| VH Pharma Beveren-Kruibeke-Zwijndrecht | €0.9m | €99,456 | 26.9% | 0 |
| EB Retail Wingene | €0.8m | €95,108 | 42.8% | 0 |
| JOKE DANIELS Hasselt | €0.9m | €121,529 | 19.8% | 0 |
| BEIRENS INVEST Zuienkerke | €0.8m | €123,415 | 51.4% | 0 |
| Pro-Tinue Roeselare | €1.1m | €122,565 | 12.9% | 0 |
| Lima Sierra Oudsbergen | €0.8m | €79,015 | 55.2% | 0 |
| Hoofd-De Wachter Sint-Katelijne-Waver | €1.0m | €96,159 | 41.9% | 0 |
These companies have the same main activity as VH Pharma: activities of holding companies (NACE 64210). They are comparable in size and age: total assets between €811,000 and €1.1m, founded between 2021 and 2023.
Official details
Source: KBO- Status
- Active since 06-07-2022Normal situation
- Activity
- Activities of holding companiesNACE 64210
- Establishment unit
- 2.333.797.5312070 Beveren-Kruibeke-Zwijndrecht, since 06-07-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 05-06-2024
Annual accounts 2025
- €879,283▼ 10.2%
- Filing
- Filed on 15-07-2026, 16 days before the end of the filing period
Insights on VH Pharma
VH Pharma files the abbreviated format. That format states no turnover. The gross margin rose from €30,129 in 2022 to €99,456 in 2025.
The balance sheet grew most from 2023 to 2024 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about VH Pharma
- What is the company number of VH Pharma?
- The company number of VH Pharma is 0788.292.373. The VAT number is the same number with BE in front: BE 0788.292.373.
- Where is VH Pharma based?
- The registered office is at Neerbroek 44, 2070 Beveren-Kruibeke-Zwijndrecht.Company details
- What does VH Pharma do?
- According to the KBO register, the main activity is activities of holding companies (NACE 64210).
- What is the legal form of VH Pharma?
- VH Pharma is a private limited company (BV).
- When was VH Pharma founded?
- VH Pharma was founded on 06-07-2022.
- Is VH Pharma still active?
- Yes, VH Pharma is an active enterprise in the KBO register.
- What is the turnover of VH Pharma?
- The turnover in financial year 2025 is ≈ €240,000. This figure is estimated from the gross margin of €99,456 and 40 comparable companies (NACE 64210). It probably lies between €150,000 and €280,000.Financials
- Is VH Pharma profitable?
- In financial year 2025, VH Pharma made a profit of €38,454.
- Where can I find the annual accounts of VH Pharma?
- VH Pharma filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of VH Pharma due?
- VH Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See what changed in the latest annual accounts.What changed See this company's board, registered office and name on a given date.Company as of a date
See how customers, suppliers and banks see your own company and what to improve first.